Discovery Comm Inc (DISCK) 25.08 $DISCK Discovery

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Discovery Comm Inc (DISCK) 25.08 $DISCK

Discovery Communications to Report Third Quarter 2016 Results on Tuesday, November 1
PR Newswire - Fri Sep 02, 7:30AM CDT
Discovery Communications (Nasdaq: DISCA, DISCB, DISCK) will report third quarter 2016 results on Tuesday, November 1, 2016, at 7:00 a.m. ET. The company will host a conference call at 8:30 a.m. ET to discuss the results.
DISCK: 25.08 (+0.13), DISCB: 27.25 (+0.05), DISCA: 25.89 (+0.20)

CBS All Access Launches Ad-free Option for its Viewers
Zacks Equity Research - Zacks Investment Research - Thu Sep 01, 9:09AM CDT
CBS Corp. (CBS) has come up with a new commercial-free subscription for its over-the-top service called CBS All Access.
DISCK: 25.08 (+0.13), SSP: 17.30 (+0.39), CMLS: 0.38 (-0.01), CBS: 52.22 (+0.18)

Discovery Communications President and CEO David Zaslav to Present at Goldman Sachs' 25th Annual Communacopia Conference
PR Newswire - Mon Aug 29, 8:10AM CDT
Discovery Communications (Nasdaq: DISCA, DISCB, DISCK) today announced that President and CEO David Zaslav will present at Goldman Sachs' 25th annual Communacopia Conference at 8:50 a.m. ET on Thursday, September 22, 2016 at The Conrad Hotel in New York, NY.
DISCK: 25.08 (+0.13), DISCB: 27.25 (+0.05), DISCA: 25.89 (+0.20)

New Strong Buy Stocks for August 26th
Tirthankar Chakraborty - Zacks Investment Research - Fri Aug 26, 7:39AM CDT
New Strong Buy Stocks for August 26th
DISCK: 25.08 (+0.13), DECK: 63.20 (-0.82), FBC: 28.00 (+0.21), CLGX: 41.45 (+0.22), CMCO: 17.84 (+0.27)

Discovery Communications CFO Andrew Warren to Present at Bank of America Merrill Lynch 2016 Media, Communications and Entertainment Conference
PR Newswire - Thu Aug 25, 8:00AM CDT
Discovery Communications (Nasdaq: DISCA, DISCB, DISCK) today announced that Chief Financial Officer Andrew Warren will present at the Bank of America Merrill Lynch 2016 Media, Communications and Entertainment Conference at 9:30 a.m. PT (12:30 p.m. ET) on Thursday, September 15, 2016, at the Beverly Wilshire Hotel in Beverly Hills, CA.
DISCK: 25.08 (+0.13), DISCB: 27.25 (+0.05), DISCA: 25.89 (+0.20)

Zacks.com featured highlights: Macy's, Discovery Communications, Zoetis, Boston Scientific and Priceline Group
Zacks Equity Research - Zacks Investment Research - Mon Aug 22, 8:30AM CDT
Zacks.com featured highlights: Macy's, Discovery Communications, Zoetis, Boston Scientific and Priceline Group
BSX: 24.26 (-0.07), ZTS: 51.26 (+0.15), DISCK: 25.08 (+0.13), M: 36.64 (+0.30), PCLN: 1,422.85 (+4.26)


Viacom CEO is out as the company settles Redstone lawsuits
AP - Fri Aug 19, 6:57PM CDT
SAN FRANCISCO (AP) — The messy legal battle over Sumner Redstone's media empire appears to have come to an end.
DISCK: 25.08 (+0.13), VIA: 44.70 (+0.28), DISCB: 27.25 (+0.05), DISCA: 25.89 (+0.20), VIAB: 39.90 (+0.13)

5 Top ROE Stocks to Play in an Aging Bull Market
Supriyo Bose - Zacks Investment Research - Fri Aug 19, 7:05AM CDT
As investors scout for cherry pickings in an aging bull market, they are often on the lookout for "cash cow" stocks that would enable them to milk more cash or profits.
ZTS: 51.26 (+0.15), BSX: 24.26 (-0.07), DISCK: 25.08 (+0.13), M: 36.64 (+0.30), PCLN: 1,422.85 (+4.26)

Services Stocks on Investors' Radar -- Discovery Communications, Wayfair, E-Commerce China Dangdang, and Shaw Communications
PR Newswire - Thu Aug 11, 6:50AM CDT
Stock-Callers.com is currently reviewing the recent performances of these four Services equities: Discovery Communications Inc. (NASDAQ: DISCK), Wayfair Inc. (NYSE: W), E-Commerce China Dangdang Inc. (NYSE: DANG), and Shaw Communications Inc. (NYSE: SJR). As per financial-services firm JPMorgan, the sector is expected to experience slow and steady progress during the coming months. Learn more about these stocks by downloading their comprehensive and free reports at:
SJR: 20.37 (+0.20), W: 38.79 (-0.50), DISCK: 25.08 (+0.13), DANG: 6.53 (+0.08)


Asian stocks slip as US fall fans angst over global growth
By YURI KAGEYAMA - AP - Tue Aug 02, 9:54PM CDT
TOKYO (AP) — Asian markets slipped Wednesday after U.S. stocks took their biggest loss in almost a month, underscoring simmering worries about global economic growth.
SPLS: 8.56 (+0.05), BCS: 9.31 (+0.18), DISCK: 25.08 (+0.13), RCL: 70.01 (-2.70), C: 47.51 (+0.15), DISCB: 27.25 (+0.05), DISCA: 25.89 (+0.20), JWN: 51.87 (+0.84), GM: 32.16 (+0.36), MS: 31.89 (-0.02)

Royal Caribbean and General Motors fall; CVS advances
AP - Tue Aug 02, 3:51PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Tuesday:
MNK: 72.42 (-3.17), DISCK: 25.08 (+0.13), F: 12.50 (+0.06), DAL: 37.17 (+0.35), PFE: 34.77 (+0.09), STX: 33.92 (+0.21), DISCB: 27.25 (+0.05), DISCA: 25.89 (+0.20), CVS: 93.84 (+0.47), GM: 32.16 (+0.36)

Discovery Communications Reports Second Quarter 2016 Results
PR Newswire - Tue Aug 02, 6:00AM CDT
Second Quarter 2016 Financial Highlights:
DISCK: 25.08 (+0.13), DISCB: 27.25 (+0.05), DISCA: 25.89 (+0.20)

Investigation Discovery And American Media, Inc., Partner To Investigate One Of Modern History's Coldest Cases In JONBENÉT: AN AMERICAN MURDER MYSTERY (wt)
PR Newswire - Mon Aug 01, 5:15PM CDT
It was the crime that gripped the nation--a bright, beaming, 6-year old beauty queen is mysteriously murdered in her very own home the day after Christmas in 1996. Investigators navigated false leads, a heavily compromised crime scene and a maze of finger-pointing. But now, 20 years later, Investigation Discovery (ID) in an unprecedented partnership with Weinstein Television, Jupiter Entertainment and American Media, Inc. (AMI)--parent company to RadarOnline and The National ENQUIRER, who have closely followed every lead and every step of the case--sheds new light on the still-unsolved case of who killed JonBenét Ramsey. In a three-night television event beginning Monday, September 12 at 10/9c, ID rips this cold case open with JONBENÉT: AN AMERICAN MURDER MYSTERY (wt), chronologically reexamining the evidence to challenge long-held beliefs at the center of this enduring mystery. The series will also premiere within Discovery Networks International's portfolio of factual and lifestyle channels in more than 220 countries and territories this fall.
DISCK: 25.08 (+0.13), DISCB: 27.25 (+0.05), DISCA: 25.89 (+0.20)

Investigation Discovery Books Deal With World's Bestselling Author On All-New Scripted Series
PR Newswire - Mon Aug 01, 5:15PM CDT
Investigation Discovery (ID) today announced a development deal with renowned author James Patterson to write and executive produce a six-part, fully scripted series for the network. The series will be based on all-new, ID-branded, true crime stories written for Patterson's new line of novella-length stories, BookShots--pulse-pounding thrillers available for under $5 and 150 pages or less--featuring mutually agreed-upon story topics. ID-branded BookShots will be released in conjunction with the on-air premiere of this series, set to debut on ID in 2017.
DISCK: 25.08 (+0.13), DISCB: 27.25 (+0.05), DISCA: 25.89 (+0.20)

Discovery Communications Statement Regarding Brexit Vote
PR Newswire - Fri Jun 24, 11:32AM CDT
Discovery Communications (Nasdaq: DISCA, DISCB, DISCK) today issued the following statement on the U.K. Brexit vote.
DISCK: 25.08 (+0.13), DISCB: 27.25 (+0.05), DISCA: 25.89 (+0.20)


Viacom CEO's tenure may be up soon after board shake-up
By RYAN NAKASHIMA - AP - Thu Jun 16, 7:44PM CDT
LOS ANGELES (AP) — Viacom CEO Philippe Dauman may not have much time left at the entertainment conglomerate.
DISCK: 25.08 (+0.13), VIA: 44.70 (+0.28), DISCB: 27.25 (+0.05), DISCA: 25.89 (+0.20), CBS.A: 52.57 (+0.26), VIAB: 39.90 (+0.13), CBS: 52.22 (+0.18)

Why Discovery Communications (DISCK) Stock Might be a Great Pick
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 7:30AM CDT
Discovery Communications (DISCK) looks like an interesting choice for investors, as it is seeing solid estimate revisions and belongs to a great industry.
DISCK: 25.08 (+0.13)

Investigation Discovery To Premiere "ADNAN SYED: INNOCENT OR GUILTY?" on Tuesday, June 14th At 9/8c As Maryland Court Considers Possible Retrial For Syed Based On Critical Evidence
PR Newswire - Tue May 31, 8:23AM CDT
Fans of the hit podcast "Serial" may soon learn the latest twist in the case of Adnan Syed, who was convicted for the 1999 murder of his former high school girlfriend, Hae Min Lee. As the decision for Syed's possible retrial looms, Investigation Discovery (ID) presents ADNAN SYED: INNOCENT OR GUILTY? examining the new evidence, brought to light by "Serial" and others, that was submitted to Maryland courts. Premiering Tuesday, June 14 at 9/8c, ADNAN SYED: INNOCENT OR GUILTY? is produced by ABC's Lincoln Square Productions, and features ABC News correspondent Ryan Smith as he uncovers the latest intriguing developments in the story, and takes an in-depth look at the new evidence through the eyes of key players surrounding the case.
DISCK: 25.08 (+0.13), DISCB: 27.25 (+0.05), DISCA: 25.89 (+0.20)


The highest-paid CEOs by state
By The Associated Press - AP - Wed May 25, 12:08PM CDT
Here are the top-paid CEOs by state for 2015, as calculated by The Associated Press and Equilar, an executive data firm.
DISCK: 25.08 (+0.13), DISCB: 27.25 (+0.05), DISCA: 25.89 (+0.20), LLY: 76.85 (-0.38)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading